Dexcom (DXCM) EPS (Weighted Average and Diluted) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.66% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.81% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.98% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 27.51% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.01% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 3.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.98% |
| Dec 31, 2025 | 44.95% |
| Sep 30, 2025 | 42.88% |
| Jun 30, 2025 | 55.36% |
| Mar 31, 2025 | 5.49% |
| Dec 31, 2024 | 242.00% |
| Sep 30, 2024 | 17.42% |
| Jun 30, 2024 | 22.59% |
| Mar 31, 2024 | -13.69% |
| Dec 31, 2023 | 100.83% |
| Sep 30, 2023 | -26.49% |
| Jun 30, 2023 | -16.45% |
| Mar 31, 2023 | -17.02% |
| Dec 31, 2022 | -39.63% |
| Sep 30, 2022 | -21.70% |
| Jun 30, 2022 | 44.22% |
| Mar 31, 2022 | 40.38% |
| Dec 31, 2021 | 82.98% |
| Sep 30, 2021 | -26.08% |
| Jun 30, 2021 | -17.63% |
| Mar 31, 2021 | 58.74% |
| Dec 31, 2020 | 3.13% |
| Sep 30, 2020 | 237.67% |
| Jun 30, 2020 | 151.98% |
| Jun 30, 2019 | 20.81% |
| Sep 30, 2018 | 43.92% |
| Jun 30, 2018 | 106.46% |
| Sep 30, 2017 | 37.00% |
| Jun 30, 2017 | 32.64% |
| Jun 30, 2016 | -19.95% |